MEDDESKTOP

NPI Registry, International Classification of Diseases,ICD,HCPCS, , CPT, National Drug Codes,NDC, SNOMED CT, MEDCIN, Medical news, Health news, Healthcare news, General welfare, and healthy living will bring forth a healthy society. This site is not intended to provide medical advice, diagnosis or treatment. Disclosure; This site shows ads compensated for them.

Friday, April 05, 2019

Health Canada Advisory, GlaxoSmithKline's Pr BENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury.

GlaxoSmithKline's Pr BENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury -Health Canada

Health Canada Advisory

ravenII at 4:04 AM

No comments:

Post a Comment

View web version

Contributors

OncoWikia
ravenII
sol@rion

Powered by Blogger.